02 Reporting

Rebate Reporting &
Transparency

Most rebate vendors give you one report. VativoRx delivers a structured reporting suite — monthly operational outputs, quarterly strategic reviews, and an advisory layer that goes beyond tracking what happened to informing what should happen next.

Schedule a Discovery Call
The Challenge

Why Reporting Breaks Down

When rebate reporting comes from multiple vendors in multiple formats, nobody has the full picture. Finance is reconciling one view, compliance is reviewing another, operations is working from a third.

Beyond the fragmentation problem, most reporting only tells you what was submitted and what was received. It doesn't tell you what you're missing — or what a different formulary decision could mean for next quarter's rebate picture.

A reporting suite should do more than document outcomes. It should give every stakeholder what they need to act — without requiring a custom request or a manual translation step between the data and the decision.

× × ×
What We Do

Structured Reporting Across All Stakeholders

VativoRx produces a defined reporting suite across every engagement — organized by cadence and audience so each stakeholder receives the output structured for their role.

Monthly outputs keep finance and operations current between quarters. Quarterly reviews give leadership and finance the context they need for planning and reconciliation. The advisory layer goes further — turning the reporting into a prompt for better decisions, not just a record of past ones.

The Six Report Types

Every report in the suite has a defined audience, a defined cadence, and a defined purpose. Nothing is produced on request — everything is structured into the program from the start.

Monthly Claims Summary Report
Monthly
A structured summary of claims submitted during the review month — giving finance and operations teams a consistent, cycle-over-cycle view of submission activity. Supports month-end review without requiring a dive into individual claim detail.
Answers

How many claims were submitted this month? What was activity volume across our drug mix?

Finance Operations Program Mgmt
Monthly Detailed Claims Report
Monthly
A claim-level breakdown of monthly submission activity — including rebate eligibility status, drug identifiers, and categorization detail. The supporting documentation behind the summary view, for teams that need to reconcile or trace at the individual claim level.
Answers

Which specific claims were submitted? What was the rebate eligibility status of each?

Finance Revenue Integrity Compliance
Quarterly Summary Report
Quarterly
A structured review of rebate activity across the full quarter — consolidating submission volume, eligibility outcomes, and program performance into a single view. Designed for quarterly account review conversations with internal and client-facing stakeholders.
Answers

How did the quarter perform? What is the story across the full rebate cycle?

Finance Leadership Program Oversight
Quarterly Estimates Report
Quarterly
A forward-looking view of expected rebate activity for the coming quarter, based on current claim volume and program participation. Supports budget planning and financial forecasting without requiring close-cycle finalization.
Answers

What should we expect to receive next quarter? How do we plan around rebate timing?

Finance FP&A Budget Planning
Rebate Remittance Report
Quarterly — Aligned to payment cycles
A detailed record of rebate payments received — organized by drug, program, and period. Provides the documentation needed to reconcile actual received amounts against submitted claims and estimated activity, and supports internal accounting close.
Answers

What was actually paid out? How does it reconcile against what was submitted and estimated?

Finance Accounting Revenue Integrity
Therapeutic Drug Alternatives Report
Ongoing / as needed
An advisory output that identifies alternative drug options for therapies not currently rebate-eligible — where substitutes exist that carry manufacturer rebate programs and fit the clinical context. Helps organizations evaluate formulary and purchasing decisions through a rebate-visibility lens without displacing clinical judgment.
Answers

Are there rebate-eligible alternatives to drugs currently outside our programs? Where might a formulary conversation be worth having?

Pharmacy Leadership Finance Clinical Ops

See What a Structured Reporting Suite Looks Like

A Discovery Call is the fastest way to understand how the reporting framework maps to your stakeholders, your cadence, and the decisions your team needs to make each cycle.

Schedule a Discovery Call  →